Fig. 6

DMBT1 secretion is suppressed in saliva from untreated SCC patients. DMBT1 levels were analyzed at baseline and 6 and 12 months for each patient. A Representative immunoblots of DMBT1 in saliva samples normalized to sample volume. B, C Log-transformed values. P values were determined using linear mixed models with compound symmetric variance structure assumed and baseline as a reference category. B Densitometric quantification of immunoblot data normalized to sample volume. C DMBT1 levels in saliva samples as determined by ELISA. D, E Each DMBT1 measure from immunoblot and ELISA quantification, respectively, was log-transformed